Skip to content

Reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea

Reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06603441
Enrollment
152
Registered
2024-09-19
Start date
2024-12-17
Completion date
2025-12-23
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea of Adult

Brief summary

The study will test the reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea (OSA)

Detailed description

A prospective cohort of 150 individuals 22 years or older with a prior diagnosis or with a high likelihood of having moderate to severe OSA, screened using STOP-Bang and Epworth Sleepiness Scale questionnaires will be recruited and will utilize the Samsung Galaxy Watch technology to monitor sleep patterns, oxygen saturation, PPG, and heart rate variability amongst other physiologic parameters. All data will be collected over the course of two intervention nights in the sleep lab and at home for three nights.

Interventions

DIAGNOSTIC_TESTSamsung Galaxy Watch

Samsung Galaxy Watch technology to monitor sleep patterns, oxygen saturation, PPG, and heart rate variability amongst other physiologic parameters.

Sponsors

Stanford University
Lead SponsorOTHER
Samsung Electronics
CollaboratorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 22 years of age or older * High pre-test likelihood of moderate to severe obstructive sleep apnea (OSA) based on screening questionnaires (STOP-Bang and Epworth Sleepiness Scale); or prior diagnosis of moderate-severe OSA. * Able to provide informed consent confirmation

Exclusion criteria

* Severe and/or other acute medical illnesses as determined by the Investigator, in particular: Cardiac conditions such as Congestive Heart Failure (CHF), atrial fibrillation, Hx of Movement disorders: Parkinson's, Tremor, Lung conditions: Chronic Obstructive Pulmonary Disease (COPD), chronic bronchitis, emphysema, pulmonary fibrosis, acute episode of flu, allergies, asthma. * Active comorbid sleep disorders, such as severe insomnia, restless legs syndrome, Periodic Leg Movement During Sleep (PLMS), narcolepsy, idiopathic hypersomnia * Severe and/or unstable psychiatric disorders such as mood, anxiety, or psychotic disorders * Individual has a condition the Investigator believes would interfere with his or her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk * Inability to use a Samsung Galaxy device for sleep tracking * Inability to have two nights in the Stanford sleep lab. * Participants who are pregnant * Tattoos or scars covering the forearm area of both hands

Design outcomes

Primary

MeasureTime frameDescription
4% Apnea Hypopnea Index (AHI)Day 1 (Visit 1), Day 5 (Visit 2)Assessment of the 4% Apnea Hypopnea Index to determine the severity of sleep apnea

Secondary

MeasureTime frameDescription
User acceptance and feasibility of Galaxy Watch technologyDay 1 (Visit 1), Day 5 (Visit 2), At home monitoring (Day 2, 3 &4)Evaluation of, * Ease of use (scored from 1-5, where 1 indicates low ease of use and 5 indicates high ease of use) * Comfort (scored from 1-5, where 1 indicates low comfort and 5 indicates high comfort) * Compliance (dropout rate and the number of nights and hours of sleep recorded for each participant)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORRobson Capasso, MD

Stanford University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 16, 2026